Spurious Drug Factory Busted In Gandhinagar

Ahmedabad: The Gujarat Food and Drug Administration (FDCA) raided a factory operating illegally within the Gujarat Industrial Development Corporation (GIDC) estate in Gandhinagar. The unit, owned by Bhavin Patel, was making medicines with a licence. The authorities suspect the factory was supplying “substandard and potentially harmful drugs across the state”, a press release from Gujarat FDCA said.

Gujarat FDCA commissioner H G Koshia said the raid unearthed a web of irregularities. Patel allegedly used fake production licences and did not have a qualified technician on the staff. Investigators suspect tablet fillers such as dibasic calcium phosphate (DCP) or starch were being used with no or improper active pharmaceutical ingredients (APIs) in medication that was sold as azithromycin, paracetamol, methylcobalamin (a vitamin B12 drug), pregabalin (analgesic) and thiocolchicoside (rheumatism drug).

“We found that they had replaced methylcobalamin, pregabalin and thiocolchicoside with DCP, starch or cheaper APIs and sold these spurious medicines. We have taken samples and are filing a case against them,” Koshia said.

Patel allegedly obtained fake production licences and GSTIN/UIN to set up the factory. “He procured the machinery to make tablets and capsules and had even secured a bank loan. Dummy pellets, empty capsule shells, omeprazole capsules, omeprazole pellets and maize starch powder were found at the factory,” Koshia added. The raid led to seizures of machinery, packaging material and counterfeit APIs, worth about Rs 4 crore.

Raw materials and finished products valued at Rs 43 lakh were also seized, the Gujarat FDCA statement said.

Related Posts

  • Pharma
  • May 16, 2025
  • 100 views
Trump targets Big Pharma with drug price order; Indian generics seen gaining edge

US President Donald Trump’s move to slash prescription drug prices by tying them to rates in countries such as the UK and Germany may rattle multinational pharmaceutical giants, but it…

  • Pharma
  • May 16, 2025
  • 97 views
Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

Emcutix Biopharmaceuticals Ltd in partnership with Canada-based Mantra Pharma Inc—both subsidiaries of Emcure Pharmaceuticals Ltd—has launched Ureaderm 10% and 20%, a new range of urea-based moisturizers designed to address severe dryness…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Trump targets Big Pharma with drug price order; Indian generics seen gaining edge

Trump targets Big Pharma with drug price order; Indian generics seen gaining edge

Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

Emcutix and Mantra Pharma Introduce Ureaderm: Advanced Urea-Based Moisturizers for Indian Skin

DCA seizes syrup stocks over misleading fever cure claim

DCA seizes syrup stocks over misleading fever cure claim

Mankind Pharma Faces Rs 341.86 Cr Tax Demand

Mankind Pharma Faces Rs 341.86 Cr Tax Demand

Piramal Pharma stock falls 5% after Q4 results; check key numbers here

Piramal Pharma stock falls 5% after Q4 results; check key numbers here

Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease

Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease